NevBio Luncheon: Will Supreme Court Gut Claims Against Drugs Companies? – Nov 24
“Pre-empted: Will The Supreme Court Gut Product Defect Claims Against Drugs Approved By The FDA?”
Find Out at a Joint Meeting with NevBio & Boyd School of Law – Intellectual Property Law Society
Kelly Evans, Esq., Snell & Wilmer
Monday-November 24th
UNLV’s Boyd School Law Bldg Room 102
12:30 PM – Lunch & Lecture ($20)
UNLV at 4505 S. Maryland Pkwy, Las Vegas, NV 89154
Please RSVP at 702-839-7222 or e-mail jlaub@regenmd.org
Kelly Evans, Partner at Snell & Wilmer, will be discussing the case of Wyeth v. Levine that was argued at the Supreme Court on November 3, 2008. If the Supreme Court rules in favor of Wyeth in the Levine case then it may result in the preemption of a broad category of mass tort pharma cases that have recently resulted in huge verdicts against pharma companies (i.e. Vioxx). This is a closely watched case for both the pharmaceutical and legal industries.
Kelly Evans is a partner at Snell & Wilmer where his practice is focused on product liability defense, employment, and intellectual property litigation. His product liability litigation focuses on defending automotive and pharmaceutical manufacturers. Kelly’s employment litigation practice includes representing employers in discrimination, harassment, wrongful discharge, and contractual matters. His intellectual property litigation concentrates on unfair competition, trade secrets, restrictive covenants, and trademark and patent infringement. Kelly has extensive experience in state and federal court, and before administrative agencies.
…
